Generali Asset Management
BNTX icon

Generali Asset Management’s BioNTech BNTX Stock Holding History

Generali Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$688 Hold
7
– – ﹤0.01% 503
2026
Q2 		$651 Hold
7
– – ﹤0.01% 525
2026
Q1 		$622 Hold
7
– – ﹤0.01% 483
2025
Q4 		$666 Hold
7
– – ﹤0.01% 482
2025
Q3 		$690 Hold
7
– – ﹤0.01% 498
2025
Q2 		$745 Hold
7
– – ﹤0.01% 497
2025
Q1 		$637 Hold
7
– – ﹤0.01% 493
2024
Q4 		$798 Buy
+7
New +$799 ﹤0.01% 478

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Davern Capital Partners
Davern Capital Partners Ny, New York $514M AUM 16.9% 1-Year Est. Return
GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Generali Asset Management's BNTX Position: Q3 2026 in Review

Generali Asset Management held its BioNTech (BNTX) position steady in Q3 2026 at 7 shares worth $688. The position accounts for ﹤0.01% of the portfolio, ranked #503.

Generali Asset Management first reported a position in BNTX in Q4 2024 and has held it in 8 quarters since. The position peaked at $798 in Q4 2024. 184 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

  • Generali Asset Management held 7 shares of BioNTech worth $688 as of Q3 2026.
  • Generali Asset Management left its BioNTech share count unchanged in Q3 2026.
  • BioNTech made up ﹤0.01% of Generali Asset Management's portfolio in Q3 2026, its #503 holding.
  • Generali Asset Management first reported a position in BioNTech in Q4 2024 and has held it in 8 quarters since.
  • Generali Asset Management's BioNTech position peaked at $798 in Q4 2024.
  • 184 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on Generali Asset Management's 13F filing for Q3 2026, filed 26 Oct 2026.